BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

758969

544497

AHCL

img img img img
No Data Available

Anlon Healthcare Ltd performance

Today’s low

Today’s high

₹ 143.50 ₹ 155.80
₹ 151.59

52 week low

52 week high

₹ 90.78 ₹ 172.75
₹ 151.59

Open Price

₹ 143.50

Prev. Close

₹ 149.54

Volume (Shares)

196935.00

Total traded value

₹ 298.53

Upper Circuit

₹ 157.01

Lower Circuit

₹ 142.06

info

Anlon Healthcare Ltd Share Price Update

As of the latest trading session, Anlon Healthcare Ltd share price is currently at ₹ 153.5, which is up by ₹ 3.96 from its previous closing. Today, the stock has fluctuated between ₹ 143.50 and ₹ 155.80. Over the past year, Anlon Healthcare Ltd has achieved a return of [-] %. In the last month alone, the return has been 10.77 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Anlon Healthcare Ltd fundamentals


  • Market cap (Cr)

    805.70

  • P/E Ratio (TTM)

    38.81

  • Beta

    1.03

  • Book Value / share

    37.90

  • Return on equity

    40.45%

  • EPS (TTM)

    3.86

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    9.32

info icon alternate text
  • Market cap (Cr)

    815.30

  • P/E Ratio (TTM)

    38.81

  • Beta

    1.05

  • Book Value / share

    37.90

  • Return on equity

    40.45%

  • EPS (TTM)

    3.86

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    9.32

info icon alternate text

Anlon Healthcare Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 52.20
Operating Expense 39.79
Net Profit 9.32
Net Profit Margin (%) 17.85
Earnings Per Share (EPS) 2.22
EBITDA 13.76
Effective Tax Rate (%) 25.14
Particulars JUN 2025 (Values in Cr)
Revenue 33.30
Operating Expense 28.31
Net Profit 3.55
Net Profit Margin (%) 10.66
Earnings Per Share (EPS) 0.89
EBITDA 6.25
Effective Tax Rate (%) 29.20
Particulars SEP 2024 (Values in Cr)
Revenue 24.17
Operating Expense 18.05
Net Profit 2.59
Net Profit Margin (%) 10.71
Earnings Per Share (EPS) 0.41
EBITDA 7.56
Effective Tax Rate (%) 57.95
Particulars JUN 2024 (Values in Cr)
Revenue 37.83
Operating Expense 32.43
Net Profit 4.54
Net Profit Margin (%) 12.00
Earnings Per Share (EPS) 2.83
EBITDA 6.90
Effective Tax Rate (%) 16.84
Particulars MAR 2025 (Values in Cr)
Revenue 120.29
Operating Expense 93.57
Net Profit 20.52
Net Profit Margin (%) 17.05
Earnings Per Share (EPS) 6.37
EBITDA 32.38
Effective Tax Rate (%) 23.68
Particulars MAR 2024 (Values in Cr)
Revenue 66.58
Operating Expense 56.94
Net Profit 9.66
Net Profit Margin (%) 14.50
Earnings Per Share (EPS) 6.68
EBITDA 15.57
Effective Tax Rate (%) 0.92
Particulars MAR 2023 (Values in Cr)
Revenue 112.88
Operating Expense 106.13
Net Profit 5.82
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 4.85
EBITDA 12.66
Effective Tax Rate (%) 16.73
Particulars MAR 2022 (Values in Cr)
Revenue 57.14
Operating Expense 57.64
Net Profit -0.11
Net Profit Margin (%) -0.19
Earnings Per Share (EPS) 0.08
EBITDA 5.80
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 20.18
ROE % 40.45
ROCE % 24.78
Total Debt to Total Equity 1.46
EBITDA Margin 27.19
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.14
ROE % 53.80
ROCE % 14.82
Total Debt to Total Equity 5.34
EBITDA Margin 23.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 6.15
ROE % 70.85
ROCE % 14.62
Total Debt to Total Equity 14.88
EBITDA Margin 11.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1.30
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 36.03
EBITDA Margin 10.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 32.12
EBITDA Margin -30.29
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.44
Total Assets 181.29
Total Liabilities 181.29
Total Equity 80.42
Share Outstanding 39851500
Price to Book Ratio 0.00
Return on Assets (%) 11.31
Return on Capital (%) 14.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.27
Total Assets 128.00
Total Liabilities 128.00
Total Equity 21.03
Share Outstanding 16000000
Price to Book Ratio 0.00
Return on Assets (%) 7.54
Return on Capital (%) 10.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.62
Total Assets 111.54
Total Liabilities 111.54
Total Equity 7.37
Share Outstanding 12000000
Price to Book Ratio 0.00
Return on Assets (%) 5.21
Return on Capital (%) 7.89
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.54
Total Assets 84.97
Total Liabilities 84.97
Total Equity 1.55
Share Outstanding 12000000
Price to Book Ratio 0.00
Return on Assets (%) -0.12
Return on Capital (%) -0.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.87
Total Assets 71.16
Total Liabilities 71.16
Total Equity 1.66
Share Outstanding 12000000
Price to Book Ratio 0.00
Return on Assets (%) -14.39
Return on Capital (%) -18.51
Particulars MAR 2025 (Values in Cr)
Net Income 26.88
Cash from Operations -21.52
Cash from Investing 2.78
Cash from Financing 18.94
Net change in Cash -0.82
Free Cash Flow -20.99
Particulars MAR 2024 (Values in Cr)
Net Income 9.75
Cash from Operations -3.21
Cash from Investing -3.36
Cash from Financing 8.24
Net change in Cash 1.65
Free Cash Flow 0.31
Particulars MAR 2023 (Values in Cr)
Net Income 6.99
Cash from Operations -2.84
Cash from Investing -0.33
Cash from Financing 2.26
Net change in Cash -0.91
Free Cash Flow -2.47
Particulars MAR 2022 (Values in Cr)
Net Income -0.10
Cash from Operations -1.76
Cash from Investing -0.38
Cash from Financing 2.80
Net change in Cash 0.66
Free Cash Flow -1.28
Particulars MAR 2021 (Values in Cr)
Net Income -9.90
Cash from Operations -15.02
Cash from Investing -2.48
Cash from Financing 15.68
Net change in Cash -1.82
Free Cash Flow -14.76
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 5769.60 31.33 2.87 16986.71 4882.00 / 7793.00
BASF INDIA LTD 4088.95 47.98 4.67 17699.28 4066.00 / 5944.30
ORIENTAL AROMATICS LIMITED 302.65 104.00 1.53 1018.53 252.40 / 487.95
DEEPAK FERTILISERS & PETROCHEM 1310.15 16.80 2.53 16539.05 888.25 / 1776.95
DEEPAK NITRITE LTD 1521.75 39.06 3.76 20755.61 1514.50 / 2771.10
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 209.60 381.09 5.07 18.86 168.70 / 275.95
ATUL LTD 5769.60 34.78 2.92 16986.71 4882.00 / 7793.00
BASF INDIA LTD 4088.95 46.01 4.64 17699.28 4066.00 / 5944.30
ORIENTAL AROMATICS LIMITED 302.65 32.47 1.47 1018.53 252.40 / 487.95

Anlon Healthcare Ltd shareholding pattern

Holding

44.48%
52.67%
2.82%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Anlon Healthcare Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
151.59 1.37 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 158.00
  • 26 Days 149.50
  • 10 Days 157.80
  • 50 Days 139.10
  • 12 Days 157.00
  • 100 Days 132.40
  • 20 Days 152.60
  • 200 Days 132.40
160.11 PIVOT

First Support

154.73

First Resistance

162.81

Second Support

152.03

Second Resistance

168.19

Third Support

146.65

Third Resistance

170.89

RSI

51.01

ADX

58.09

MACD

7.48

Williams % R

-74.27

Commodity Channel Index (CCI)

-7.35

Date

2025-09-24

Week

773306.00

Same Day

658704.00

Month

773306.00

1 Year

1.03

3 Year

0.94

Over 1 Month

10.77%

down

Over 1 Year

0.00%

down

Over 3 Months

63.02%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Anlon Healthcare Ltd Corporate Actions

Anlon Healthcare Ltd Share Price

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC.

Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs. They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction. It serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products.

In addition to manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, the Company has recently started undertaking custom manufacturing services for complex or novel chemical compounds. The Company started commercial production of Pharma Intermediate and API in 2018. It work out manufacturing activities at Rajkot, Gujarat, which comprise of two separate manufacturing blocks for manufacturing of Pharmaceutical Intermediate and APIs respectively with an aggregate installed production capacity of 400 MTPA.

The Company launched the Initial Public Offering of 1,33,00,000 equity shares having the face value of Rs 10, by raising funds aggregating to Rs 121.03 Cr via fresh issue in August 2025.

Parent organization Indian Private
NSE symbol AHCL
Founded 2013
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Anlon Healthcare Ltd?

Answer Field

Anlon Healthcare Ltd share price is for NSE ₹ 153.50 & for BSE ₹ 154.70 as on Dec 04 2025 03:29 PM.

What is the Market Cap of Anlon Healthcare Ltd Share?

Answer Field

The market cap of Anlon Healthcare Ltd for NSE ₹ 805.70 & for BSE ₹ 0.00 as on Dec 04 2025 03:29 PM.

What is the 52 Week High and Low of Anlon Healthcare Ltd?

Answer Field

The 52 Week High and Low of Anlon Healthcare Ltd for NSE is ₹ 172.75 and ₹ 90.78 and for BSE is ₹ 172.00 and ₹ 86.98.

What is 1 year return for Anlon Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Anlon Healthcare Ltd Share?

Answer Field

As on Dec 04 2025 03:29 PM the price-to-earnings (PE) ratio for Anlon Healthcare Ltd share is 38.81.

What is the PB ratio of Anlon Healthcare Ltd Share?

Answer Field

As on Dec 04 2025 03:29 PM, the price-to-book (PB) ratio for Anlon Healthcare Ltd share is 37.90.

How to Buy Anlon Healthcare Ltd Share?

Answer Field

You can trade in Anlon Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Anlon Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Anlon Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Anlon Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59